Loading clinical trials...
Loading clinical trials...
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Conditions
Interventions
STP705
Locations
1
United States
Center for Clinical and Cosmetic Research
Aventura, Florida, United States
Start Date
March 21, 2019
Primary Completion Date
October 21, 2020
Completion Date
October 21, 2020
Last Updated
June 9, 2022
NCT07361666
NCT02085395
Lead Sponsor
Sirnaomics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions